Can CVS Health’s Strategic Overhaul Revitalize Its Market Position?
PYMNTS.com October 2, 2024
In the high-stakes world of healthcare retail, CVS Health finds itself at a crossroads, navigating turbulent waters amid investor pressures and a stock price that seems to be on a downward spiral.
As the pharmacy giant embarks on a strategic review, including possibly splitting its insurance and retail arms, CEO Karen S. Lynch faces the daunting task of reversing fortunes while trimming nearly 2,900 employees. With rising medical costs threatening to overshadow its insurance segment and retail sales stalling in an uncertain economy, CVS needs to find ways to attract budget-conscious shoppers and reassure investors.
Will a breakup be the lifeline CVS needs or merely a Band-Aid for deeper wounds?
Reviewing Options
CVS Health’s board has hired advisers to conduct...